Back to 
SUSQUEHANNA INTERNATIONAL GROUP, LLP
SUSQUEHANNA INTERNATIONAL GROUP, LLP
SMMT
Showing 0 of 4 quarters
Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in SUMMIT THERAPEUTICS-SPON ADR
No. Susquehanna International Group exited its SMMT (Summit Therapeutics) position in Q4 2019. Its Q3 2019 13F listed 26,491 shares worth $47,000. Susquehanna International Group already held SMMT in its Q4 2018 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.